John Pernow

13.2k total citations
272 papers, 10.3k citations indexed

About

John Pernow is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, John Pernow has authored 272 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Physiology, 118 papers in Cardiology and Cardiovascular Medicine and 69 papers in Molecular Biology. Recurrent topics in John Pernow's work include Nitric Oxide and Endothelin Effects (121 papers), Neuropeptides and Animal Physiology (53 papers) and Cardiac Ischemia and Reperfusion (51 papers). John Pernow is often cited by papers focused on Nitric Oxide and Endothelin Effects (121 papers), Neuropeptides and Animal Physiology (53 papers) and Cardiac Ischemia and Reperfusion (51 papers). John Pernow collaborates with scholars based in Sweden, Germany and United States. John Pernow's co-authors include Jan M. Lundberg, Felix Böhm, Christian Jung, Adrian Gonon, Qing‐Dong Wang, Alexey Shemyakin, Anette Hemsén, Elvar Theodorsson, Magnus Settergren and Jon O. Lundberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

John Pernow

269 papers receiving 10.1k citations

Peers

Countries citing papers authored by John Pernow

Since Specialization

Citations

This map shows the geographic impact of John Pernow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pernow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pernow more than expected).

Fields of papers citing papers by John Pernow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Pernow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pernow. The network helps show where John Pernow may publish in the future.

Co-authorship network of co-authors of John Pernow

This figure shows the co-authorship network connecting the top 25 collaborators of John Pernow. A scholar is included among the top collaborators of John Pernow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Pernow. John Pernow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium 2024 ·Cardiovascular Diabetology ·(unknown), Shafaat Hussain, Abdul Waheed Khan, Liang Zhang, Wael Almahmeed, John Pernow, Francesco Cosentino	13
2	Red blood cells as potential materials for microRNA biomarker study: overcoming heparin-related challenges 2024 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), (unknown), Ekaterina Chernogubova, Michael Alvarsson, Lars Mäegdefessel, Aida Collado, John Pernow, Zhichao Zhou	0
3	Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase 2024 ·Clinical Science ·(unknown), (unknown), Aida Collado, Jiangning Yang, Michael Alvarsson, Jonas Brinck, S Rössner, Zhichao Zhou, John Pernow, Ali Mahdi	2
4	Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction 2024 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), (unknown), (unknown), Tong Jiao, (unknown), Ulf Hedin, Zhichao Zhou, Juliane Jurga, Aida Collado, Ali Mahdi, John Pernow	0
5	Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia 2023 ·Atherosclerosis ·(unknown), Ali Mahdi, Ashwin Venkateshvaran, Henrike Häbel, (unknown), (unknown), Bo Angelin, John Pernow, Jonas Brinck	5
6	Erythrocyte-derived extracellular vesicles from type 2 diabetes patients induce endothelial dysfunction through arginase 1 2023 ·European Heart Journal ·Aida Collado, (unknown), Maria Eldh, Tong Jiao, Esteban Domingo, (unknown), (unknown), Ali Mahdi, Susanne Gabrielsson, Per Eriksson, Zhichao Zhou, John Pernow	1
7	The red blood cell as a mediator of endothelial dysfunction in patients with familial hypercholesterolemia and dyslipidemia 2022 ·Journal of Internal Medicine ·Ali Mahdi, (unknown), Oskar Kövamees, (unknown), Allan Z. Zhao, Tong Jiao, Marcus Henricsson, Jiangning Yang, Zhichao Zhou, Anni I. Nieminen, Malin Levin, Aida Collado, Jonas Brinck, John Pernow	14
8	Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial 2022 ·BMJ Open ·Anders Kjellberg, (unknown), (unknown), (unknown), (unknown), (unknown), Carl Johan Sundberg, John Pernow, (unknown), Jan Kowalski, Kenny A. Rodriguez‐Wallberg, Xiaowei Zheng, Sergiu‐Bogdan Catrina, Michael Runold, Marcus Ståhlberg, Judith Bruchfeld, Malin Nygren‐Bonnier, Peter Lindholm	15
9	Abstract 12760: Microvascular Endothelial Dysfunction in Postural Orthostatic Tachycardia Syndrome Associated With Post-Acute Sequelae of COVID-19 2022 ·Circulation ·Ali Mahdi, (unknown), Jannike Nickander, Artur Fedorowski, Liyew Desta, Malin Nygren‐Bonnier, Michael Runold, Judith Bruchfeld, John Pernow, Marcus Ståhlberg	1
10	Arginase 1 is upregulated at admission in patients with ST‐elevation myocardial infarction 2021 ·Journal of Internal Medicine ·(unknown), (unknown), Dinos Verouhis, Felix Böhm, Per Eriksson, Lasse Folkersen, Anders Gabrielsen, Tomas Jernberg, Pia Lundman, Jonas Persson, Nawzad Saleh, Magnus Settergren, Peder Sörensson, Yahor Tratsiakovich, Per Tornvall, Christian Jung, John Pernow	9
11	Therapeutic Potential of Sunitinib in Ameliorating Endothelial Dysfunction in Type 2 Diabetic Rats 2021 ·Pharmacology ·Ali Mahdi, Tong Jiao, Yahor Tratsiakovich, Bernhard Wernly, Jiangning Yang, Claes‐Göran Östenson, A.H. Jan Danser, John Pernow, Zhichao Zhou	4
12	The effect of levosimendan on survival and cardiac performance in an ischemic cardiac arrest model – A blinded randomized placebo-controlled study in swine 2020 ·Resuscitation ·(unknown), Johan Lundberg, Per Nordberg, (unknown), Björn Wieslander, (unknown), (unknown), John Pernow, Martin Ugander, Therese Djärv, Malin Jonsson Fagerlund	8
13	Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD 2020 ·Circulation Research ·Shafaat Hussain, Abdul Waheed Khan, Alexander Akhmedov, Rosa Suades, Sarah Costantino, Francesco Paneni, Kenneth Caidahl, S A Mohammed, Camilla Hage, (unknown), Hanna M. Björck, John Pernow, Lars H. Lund, Thomas F. Lüscher, Francesco Cosentino	47
14	Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction 2020 ·Contemporary Clinical Trials Communications ·Eva Prescott, John Pernow, Antti Saraste, Axel Åkerblom, Oskar Angerås, David Erlinge, Erik Lerkevang Grove, Marja Hedman, Lisette Okkels Jensen, Sara Svedlund, Michael Kjær, Maria Lagerström‐Fermér, (unknown)	9
15	Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events 2019 ·Open Heart ·Ole Fröbert, (unknown), Dorothy K. Hatsukami, John Pernow, Elmir Ömerovic, Pontus Andell	3
16	Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update 2018 ·Pharmacological Research ·Zhichao Zhou, Takayuki Matsumoto, Vera Jankowski, John Pernow, S. Jamal Mustafa, Dirk J. Duncker, Daphne Merkus	27
17	Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors 2016 ·American Journal of Physiology-Heart and Circulatory Physiology ·Zhichao Zhou, Ihsan Chrifi, Yanjuan Xu, John Pernow, Dirk J. Duncker, Daphne Merkus, Caroline Cheng	15
18	Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus 2012 ·Circulation ·Alexey Shemyakin, Oskar Kövamees, Arnar Rafnsson, Felix Böhm, Peter Svenarud, Magnus Settergren, Christian Jung, John Pernow	154
19	L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease 2008 ·European Heart Journal ·Magnus Settergren, Felix Böhm, Rickard E. Malmström, Keith M. Channon, John Pernow	1
20	ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men 2003 ·Clinical Science ·(unknown), John Pernow, (unknown), G. Ahlborg	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact